Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumorsA A Adjei, C Erlichman, J A Sloan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Cancer Research|February 24, 2001
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug effluxC Erlichman, S A Boerner, C G Hallgren, et al.
Leukemia|June 22, 2007
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemiaR A Mesa, J K Camoriano, S M Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activityA A Adjei, C E Klein, H Kastrissios, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Gene Therapy|January 14, 2005
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomasE Galanis, S H Okuno, A G Nascimento, et al.
Leukemia|October 22, 2011
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphomaS M Ansell, H Tang, P J Kurtin, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumorsA A Adjei, C Erlichman, J A Sloan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeksS R Alberts, C Erlichman, J Sloan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)E Galanis, R Goldberg, J Reid, et al.
Cancer Research|February 24, 2001
The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug effluxC Erlichman, S A Boerner, C G Hallgren, et al.
Leukemia|June 22, 2007
A phase II trial of tipifarnib in myelofibrosis: primary, post-polycythemia vera and post-essential thrombocythemiaR A Mesa, J K Camoriano, S M Geyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activityA A Adjei, C E Klein, H Kastrissios, et al.
Cancer Research|April 15, 2000
A Phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activityA A Adjei, C Erlichman, J N Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumorsH C Pitot, E A McElroy, J M Reid, et al.
Gene Therapy|January 14, 2005
Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomasE Galanis, S H Okuno, A G Nascimento, et al.
Leukemia|October 22, 2011
Denileukin diftitox in combination with rituximab for previously untreated follicular B-cell non-Hodgkin's lymphomaS M Ansell, H Tang, P J Kurtin, et al.
Pageof 10